Clinical Trial Update: Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update reports completion of Phase 2 and Phase 3 studies evaluating VR506 via a new inhaler for asthma, with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• VR506

Snippet

Sponsor: Vectura Limited | Conditions: Asthma | Phase 2, Phase 3 | Status: COMPLETED | Results posted: 2020-04-21